LI-RADS and transplantation for hepatocellular carcinoma.

Patients with hepatocellular carcinoma (HCC) may be eligible for liver transplantation. Liver transplant candidates with HCC compete for the same deceased donor organs as those without HCC. These scarce organs must be allocated fairly and justly to those who will benefit most. Unlike most other canc...

Descripción completa

Detalles Bibliográficos
Publicado en:Abdominal Radiology Vol. 43; no. 1; pp. 193 - 203
Autores principales: Tang, An, Fowler, Kathryn J., Chernyak, Victoria, Chapman, William C., Sirlin, Claude B.
Formato: Journal Article
Publicado: Springer Nature Jan2018
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=127331667&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 127331667
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        2366004X
        JT14
      jtl: Abdominal Radiology
      issn: 2366004X
      maglogo: N
    pubinfo:
      dt: Jan2018
      vid: 43
      iid: 1
      pid: 237
      pub: Springer Nature
      place: New York, New York
    artinfo:
      ui:
        127331667
        144130767
        10.1007/s00261-017-1210-8
        127331667
      ppf: 193
      ppct: 10
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: P
      tig:
        atl: LI-RADS and transplantation for hepatocellular carcinoma.
      aug:
        au:
          Tang, An
          Fowler, Kathryn J.
          Chernyak, Victoria
          Chapman, William C.
          Sirlin, Claude B.
        affil: Department of Radiology, Radio-oncology and Nuclear Medicine, University of Montreal and CRCHUM, 1058 rue Saint-Denis, H2X 3J4, Montréal, QC, Canada
      sug:
      ab: Patients with hepatocellular carcinoma (HCC) may be eligible for liver transplantation. Liver transplant candidates with HCC compete for the same deceased donor organs as those without HCC. These scarce organs must be allocated fairly and justly to those who will benefit most. Unlike most other cancers, HCC is often diagnosed noninvasively by imaging without biopsy confirmation. Therefore, radiologists play an important role in diagnosing definite HCC (i.e., LR-5 category) that counts toward staging and determination of liver transplant eligibility. This review explains the conversion of LI-RADS observation categories to organ procurement and transplantation network classes, illustrates the radiologic T-staging systems, reviews selection criteria for liver transplant eligibility, and discusses prioritization of liver transplant candidates with HCC. In addition, this review summarizes imaging requirements, including contrast agents accepted, minimum specifications for dynamic CT or MRI of the liver, and modalities accepted for assessment of extrahepatic spread or metastatic disease in liver transplant candidates with HCC.
      pubtype: Academic Journal
      doctype: Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N